Avadel's LUMRYZ: A Good Night's Sleep For Narcolepsy Patients (NASDAQ:AVDL)

Avadel's LUMRYZ (FT218), with its essential once daily dosing, has snagged a tentative approval from the FDA. See why I'm bullish on AVDL stock.

Related Keywords

Delaware ,United States ,District Of Columbia ,Viktoria Korobova ,Us Food Drug Administration ,Avadel Pharmaceuticals ,Jazz Pharmaceuticals ,Young ,Us District Court ,Orphan Drug ,Jazz Pharmaceutical ,Drug Administration ,Drug Application ,